A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection
Clinical trial NCT02442284 · COMPLETED
Trial details
- NCT number
- NCT02442284
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-13
- Primary completion
- 2016-08-22
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.